BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 839073)

  • 1. Human transfer factor: fractionation by electrofocusing and high pressure, reverse phase chromatography.
    Vandenbark AA; Burger DR; Dreyer DL; Daves GD; Vetto RM
    J Immunol; 1977 Feb; 118(2):636-41. PubMed ID: 839073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human transfer factors: structural properties suggested by HPRP chromatography and enzymatic sensitivities.
    Burger DR; Vandenbark AA; Dunnick W; Kraybill W; Daves GD; Vetto RM
    J Immunol; 1979 Mar; 122(3):1091-8. PubMed ID: 448071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human transfer factor: fractionation and biologic activity.
    Burger DR; Vandenbark AA; Daves D; Anderson WA; Vetto RM; Finke P
    J Immunol; 1976 Sep; 117(3):789-96. PubMed ID: 134121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractionation studies on human leucocyte dialyzates. Demonstration of three components with transfer factor activity.
    Krohn K; Gröhn P; Horsmanheimo M; Virolainen M
    Med Biol; 1976 Dec; 54(5):334-40. PubMed ID: 994567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of human transfer factor from KLH-immunized donors: dissociation of dermal transfer and proliferation augmenting activities.
    Burger DR; Vandenbark AA; Dunnick W; Kraybill WG; Vetto RM
    J Reticuloendothel Soc; 1978 Oct; 24(4):385-402. PubMed ID: 712720
    [No Abstract]   [Full Text] [Related]  

  • 6. Nature and antigen-specific activities of transfer factor against herpes simplex virus type 1.
    Huang LL; Su CZ; Wan ZF
    Acta Virol; 1987 Nov; 31(6):449-57. PubMed ID: 2449810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. II. Separation and partial characterization of the components in DLE producing antigen-dependent and antigen-independent effects.
    Wilson GB; Fudenberg HH
    J Lab Clin Med; 1979 May; 93(5):819-37. PubMed ID: 429877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a human lung tumor-associated antigen and development of a radioimmunoassay.
    Braatz JA; Scharfe TR; Princler GL; McIntire KR
    Cancer Res; 1982 Mar; 42(3):849-55. PubMed ID: 7059983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dialyzable products from human leukocyte extracts on cutaneous delayed-hypersensitivity response.
    Gottlieb AA; Maziarz GA; Tamaki N; Sutcliffe SB
    J Immunol; 1980 Feb; 124(2):885-92. PubMed ID: 7356716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human dialyzable transfer factor from normal and chronic lymphoid leukemia sources.
    Goust JM; Marescot MR; Lesourd B; Doumercq S; Moulias R
    Biomedicine; 1976 Jan; 24(1):39-44. PubMed ID: 817750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells.
    Veluri R; Singh RP; Liu Z; Thompson JA; Agarwal R; Agarwal C
    Carcinogenesis; 2006 Jul; 27(7):1445-53. PubMed ID: 16474170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic specificity of transfer factor.
    Zuckerman KS; Neidhart JA; Balcerzak SP; LoBuglio AF
    J Clin Invest; 1974 Oct; 54(4):997-1000. PubMed ID: 4139171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrofocusing the compost organic matter obtained by coupling SEC-PAGE.
    Cavani L; Trubetskaya O; Grigatti M; Trubetskoj O; Ciavatta C
    Bioresour Technol; 2008 Jul; 99(10):4360-7. PubMed ID: 17959377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and purification of HSV-1 specific transfer factor produced by HSV-1 immunized goat leukocyte dialysate.
    Qi HY; Wan ZF; Su CZ
    Acta Virol; 1992 May; 36(3):231-8. PubMed ID: 1360750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine 'transfer factor': an oligoribonucleopeptide which initiates antigen-specific lymphocytes responsiveness.
    Wilson GB; Paddock GV; Fudenberg HH
    Thymus; 1982; 4(6):335-50. PubMed ID: 6191411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer factor--a lymphocyte cell surface component.
    Schröder I; Lüneburg S
    Allergol Immunopathol (Madr); 1984; 12(1):1-5. PubMed ID: 6731201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rapid isolation of highly purified epidermal growth factor by reverse-phase liquid chromatography].
    Ivashchenko IuD; Osipova LA; Gut IT; Garmanchuk LV
    Eksp Onkol; 1985; 7(6):47-9. PubMed ID: 3878774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides.
    Wilson GB; Paddock GV; Fudenberg HH
    Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the purification of thrombopoietin from kidney cell culture medium.
    McDonald TP; Cottrell M; Clift R; Khouri JA; Long MD
    J Lab Clin Med; 1985 Aug; 106(2):162-74. PubMed ID: 4020244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide: suppression of lymphocyte transformation with a component identified in human transfer factor.
    Burger DR; Vandenbark AA; Daves D; Anderson WA; Vetto RM; Finke P
    J Immunol; 1976 Sep; 117(3):797-801. PubMed ID: 134122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.